Woodstock Corp Cara Therapeutics, Inc. Transaction History

Woodstock Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$8.24 - $12.56 $89,000 - $135,660	10,801 Added 30.41%	46,323 $434,000
Q1 2022 Apr 07, 2022	BUY	$9.94 - $12.65 $53,407 - $67,968	5,373 Added 17.82%	35,522 $432,000
Q1 2021 Apr 05, 2021	BUY	$15.07 - $21.71 $175,083 - $252,226	11,618 Added 62.69%	30,149 $655,000
Q4 2020 Jan 06, 2021	BUY	$12.72 - $16.16 $235,714 - $299,460	18,531 New	18,531 $280,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $247M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

Stay updated on Woodstock Corp with notifications on news.